Trial intelligence / Profile preview

Topiramate vs Peripheral Nerve Block for Medication Overuse Headache

NCT03767062Completed

Sponsor
Atatürk University
Start
Mar 2019
Primary completion
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of topiramate in medication overuse headache (MOH) and chronic migraine (2 arms), sponsored by Atatürk University. Primary endpoints: Visual Analog Scale at 4 weeks and Headache Attack Frequencies at 4 weeks. Started Mar 2019; status: completed.

02

Drugs

topiramate
03

Conditions

medication overuse headache (MOH)chronic migraine

Beyond the preview

Go deeper on NCT03767062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03767062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call